Therapy-Induced Modulation of the Tumor Microenvironment: New Opportunities for Cancer Therapies.
cancer
immunotherapy
radiotherapy
surgery
tumor microenvironment
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2020
2020
Historique:
received:
13
07
2020
accepted:
16
09
2020
entrez:
16
11
2020
pubmed:
17
11
2020
medline:
17
11
2020
Statut:
epublish
Résumé
Advances in immunotherapy have achieved remarkable clinical outcomes in tumors with low curability, but their effects are limited, and increasing evidence has implicated tumoral and non-tumoral components of the tumor microenvironment as critical mediators of cancer progression. At the same time, the clinical successes achieved with minimally invasive and optically-guided surgery and image-guided and ablative radiation strategies have been successfully implemented in clinical care. More effective, localized and safer treatments have fueled strong research interest in radioimmunotherapy, which has shown the potential immunomodulatory effects of ionizing radiation. However, increasingly more observations suggest that immunosuppressive changes, metabolic remodeling, and angiogenic responses in the local tumor microenvironment play a central role in tumor recurrence. In this review, we address challenges to identify responders vs. non-responders to the immune checkpoint blockade, discuss recent developments in combinations of immunotherapy and radiotherapy for clinical evaluation, and consider the clinical impact of immunosuppressive changes in the tumor microenvironment in the context of surgery and radiation. Since the therapy-induced modulation of the tumor microenvironment presents a multiplicity of forms, we propose that overcoming microenvironment related resistance can become clinically relevant and represents a novel strategy to optimize treatment immunogenicity and improve patient outcome.
Identifiants
pubmed: 33194719
doi: 10.3389/fonc.2020.582884
pmc: PMC7645077
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
582884Informations de copyright
Copyright © 2020 Benavente, Sánchez-García, Naches, LLeonart and Lorente.
Références
Nature. 2019 Feb;566(7744):403-406
pubmed: 30728499
Nat Med. 2006 May;12(5):557-67
pubmed: 16648859
JAMA Oncol. 2019 Jul 11;:
pubmed: 31294762
Cell. 2017 Feb 9;168(4):707-723
pubmed: 28187290
Nat Rev Clin Oncol. 2018 May;15(5):325-340
pubmed: 29508855
Nature. 2018 Feb 22;554(7693):544-548
pubmed: 29443960
Matter. 2019 Nov 6;1(5):1331-1353
pubmed: 32832885
N Engl J Med. 2018 Jun 14;378(24):2288-2301
pubmed: 29863955
Nat Rev Cancer. 2020 Apr;20(4):203-217
pubmed: 32161398
Nature. 2020 Mar;579(7798):284-290
pubmed: 32103175
Nat Med. 2004 Aug;10(8):858-64
pubmed: 15235597
Cancer Immunol Res. 2020 Apr;8(4):465-478
pubmed: 32047024
Br J Cancer. 2019 Jul;121(3):249-256
pubmed: 31239542
Front Immunol. 2019 Jan 31;9:3154
pubmed: 30766539
Anal Chem. 2018 Oct 16;90(20):12253-12260
pubmed: 30215510
Proc Natl Acad Sci U S A. 2013 Nov 12;110(46):18632-7
pubmed: 24167277
Nat Rev Cancer. 2016 Jul;16(7):447-62
pubmed: 27339708
Nat Commun. 2019 Sep 13;10(1):4186
pubmed: 31519915
Front Oncol. 2020 Jun 24;10:1027
pubmed: 32670886
Nat Rev Clin Oncol. 2018 Dec;15(12):748-762
pubmed: 30361681
Nat Immunol. 2019 Mar;20(3):265-275
pubmed: 30664738
Nat Med. 2019 Aug;25(8):1251-1259
pubmed: 31359002
Clin Cancer Res. 2019 Feb 1;25(3):946-956
pubmed: 30297458
Ann Surg Oncol. 2017 Aug;24(8):2055-2064
pubmed: 28547564
Sci Transl Med. 2017 Oct 4;9(410):
pubmed: 28978752
Proc Natl Acad Sci U S A. 2013 Dec 10;110(50):20212-7
pubmed: 24277834
Oncotarget. 2017 Feb 21;8(8):13048-13058
pubmed: 28055956
Front Immunol. 2020 May 07;11:784
pubmed: 32457745
Nat Rev Drug Discov. 2019 Feb;18(2):99-115
pubmed: 30470818
J Immunol. 2020 Jun 15;204(12):3416-3424
pubmed: 32341058
Front Oncol. 2017 Dec 22;7:314
pubmed: 29312886
Nature. 2020 Jan;577(7791):549-555
pubmed: 31942075
Cell Metab. 2019 Jan 8;29(1):124-140.e10
pubmed: 30293773
JAMA Oncol. 2020 May 1;6(5):659-660
pubmed: 32215582
Clin Cancer Res. 2019 Jun 15;25(12):3572-3580
pubmed: 30885938
Cell. 2017 Sep 7;170(6):1120-1133.e17
pubmed: 28803728
Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):728-34
pubmed: 15701862
Trends Cancer. 2018 Apr;4(4):292-319
pubmed: 29606314
Cancer Immunol Immunother. 2018 Dec;67(12):1825-1832
pubmed: 30171269
Lancet Oncol. 2019 Aug;20(8):1148-1159
pubmed: 31296491
N Engl J Med. 2019 Mar 21;380(12):1116-1127
pubmed: 30779529
JAMA Oncol. 2020 Jul 1;6(7):1039-1046
pubmed: 32525513
Cancer Cell. 2014 Nov 10;26(5):605-22
pubmed: 25517747
Oncotarget. 2017 Dec 15;9(4):4375-4384
pubmed: 29435109
Nat Commun. 2018 Jun 15;9(1):2351
pubmed: 29907739
JAMA Oncol. 2020 May 1;6(5):650-659
pubmed: 32215577
Immunity. 2017 Aug 15;47(2):323-338.e6
pubmed: 28813661
Int J Cancer. 2017 Mar 15;140(6):1331-1345
pubmed: 27888521
Proc Natl Acad Sci U S A. 2020 Jun 2;117(22):12288-12294
pubmed: 32430334
Cancer Discov. 2016 Aug;6(8):827-37
pubmed: 27301722
Cancers (Basel). 2015 Oct 14;7(4):2054-62
pubmed: 26473929
Nat Med. 2018 Dec;24(12):1845-1851
pubmed: 30397353
Nature. 2015 Nov 19;527(7578):329-35
pubmed: 26524530
Front Oncol. 2018 Mar 20;8:66
pubmed: 29616188
Cancer Immunol Res. 2017 May;5(5):357-362
pubmed: 28396509
Mol Cancer Ther. 2019 Feb;18(2):459-469
pubmed: 30413650
Neuro Oncol. 2016 Jun;18(6):797-806
pubmed: 26538619
J Clin Invest. 2020 Jan 2;130(1):51-61
pubmed: 31895048
Nature. 2019 Oct;574(7776):45-56
pubmed: 31578484
N Engl J Med. 2016 Nov 10;375(19):1845-1855
pubmed: 27717298
Future Healthc J. 2020 Feb;7(1):46-49
pubmed: 32104765
Acta Biochim Pol. 2015;62(2):265-72
pubmed: 26098714
Nat Med. 2018 May;24(5):541-550
pubmed: 29686425
Int J Nanomedicine. 2020 May 29;15:3843-3850
pubmed: 32581534
J Cell Physiol. 2018 Apr;233(4):3024-3036
pubmed: 28661031
Proc Natl Acad Sci U S A. 2019 Dec 16;:
pubmed: 31843922
Sci Rep. 2020 Jan 9;10(1):50
pubmed: 31919369
J Clin Invest. 2013 Sep;123(9):3678-84
pubmed: 23999442
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2020 Jul;12(4):e1624
pubmed: 32162485
Proc Natl Acad Sci U S A. 2019 Mar 5;116(10):4558-4566
pubmed: 30700545
Annu Rev Physiol. 2019 Feb 10;81:505-534
pubmed: 30742782
J Clin Endocrinol Metab. 2018 Oct 1;103(10):3589-3592
pubmed: 30124874
Trends Cancer. 2019 Nov;5(11):704-723
pubmed: 31735289
Genome Med. 2019 Jun 20;11(1):40
pubmed: 31221199
Cancer Immunol Immunother. 2019 Jul;68(7):1107-1120
pubmed: 31119318
Proc Natl Acad Sci U S A. 2020 Feb 18;117(7):3728-3737
pubmed: 32015113
Ann Transl Med. 2019 Mar;7(Suppl 1):S6
pubmed: 31032287
N Engl J Med. 2018 Dec 13;379(24):2342-2350
pubmed: 30280658
Int J Radiat Oncol Biol Phys. 2020 Sep 1;108(1):17-26
pubmed: 32819613
Sci Rep. 2016 Jun 08;6:27548
pubmed: 27271009
Nature. 2019 May;569(7755):270-274
pubmed: 31043744
Front Immunol. 2018 Feb 23;9:353
pubmed: 29527212
Immunity. 2018 Apr 17;48(4):812-830.e14
pubmed: 29628290
Nat Rev Cancer. 2020 Mar;20(3):174-186
pubmed: 31980749
Pharmacol Ther. 2019 Aug;200:55-68
pubmed: 30998941
Int J Radiat Oncol Biol Phys. 2020 Nov 1;108(3):734-744
pubmed: 32473180
Int J Radiat Oncol Biol Phys. 2020 Sep 1;108(1):27-37
pubmed: 32339645
Int J Radiat Oncol Biol Phys. 2007 Jun 1;68(2):499-507
pubmed: 17398016
Sci Rep. 2018 Apr 9;8(1):5686
pubmed: 29632347
Mutat Res. 2015 Feb;772:38-45
pubmed: 25772109
Clin Cancer Res. 2019 Dec 1;25(23):6948-6957
pubmed: 31537527
Nat Rev Cancer. 2016 Aug 23;16(9):582-98
pubmed: 27550820
N Engl J Med. 2019 Mar 21;380(12):1103-1115
pubmed: 30779531
Nat Rev Drug Discov. 2019 Mar;18(3):197-218
pubmed: 30610226
Nat Med. 2018 Nov;24(11):1649-1654
pubmed: 30297909
Hepatology. 2008 Feb;47(2):532-43
pubmed: 18098323
Int J Radiat Oncol Biol Phys. 2020 Aug 13;:
pubmed: 32798606
Lancet Oncol. 2019 Aug;20(8):e452-e463
pubmed: 31364597
Science. 2019 Nov 22;366(6468):1013-1021
pubmed: 31699883
Science. 2015 Apr 3;348(6230):74-80
pubmed: 25838376
Lancet Oncol. 2019 May;20(5):711-718
pubmed: 30922731
Nat Commun. 2019 Sep 2;10(1):3959
pubmed: 31477729
Int J Radiat Oncol Biol Phys. 2020 Nov 15;108(4):891-898
pubmed: 32800803
Am J Physiol Cell Physiol. 2015 Nov 1;309(9):C569-79
pubmed: 26310815
Analyst. 2017 Aug 21;142(17):3025-3047
pubmed: 28726868
Immunity. 2020 Jan 14;52(1):55-81
pubmed: 31940273
Oncoimmunology. 2019 Apr 24;8(7):1593805
pubmed: 31143513
Sci Rep. 2015 Mar 09;5:8913
pubmed: 25746680
J Clin Oncol. 2020 Apr 1;38(10):1081
pubmed: 32013670
Clin Cancer Res. 2019 Sep 1;25(17):5351-5363
pubmed: 31186314
Cancer Res. 2018 Aug 15;78(16):4586-4598
pubmed: 29880482
Breast Cancer Res. 2019 Sep 5;21(1):103
pubmed: 31488209
Theranostics. 2018 May 24;8(13):3437-3460
pubmed: 30026858
Int J Radiat Oncol Biol Phys. 2020 Sep 1;108(1):3-5
pubmed: 32819614
Physiol Rev. 2020 Aug 13;:
pubmed: 32790578
Clin Cancer Res. 2020 Feb 15;26(4):910-921
pubmed: 31757878
Sci Adv. 2018 Dec 19;4(12):eaau5603
pubmed: 30585292
Front Immunol. 2019 Feb 15;10:193
pubmed: 30828330
Pigment Cell Melanoma Res. 2018 May;31(3):404-410
pubmed: 29171176
Proc Natl Acad Sci U S A. 2019 May 14;116(20):9999-10008
pubmed: 31028147
PLoS One. 2015 Jul 24;10(7):e0130472
pubmed: 26208314
J Immunother Cancer. 2019 Sep 4;7(1):237
pubmed: 31484556
Proc Natl Acad Sci U S A. 2017 Mar 14;114(11):2934-2939
pubmed: 28246332
Cancer Res. 2010 Jul 15;70(14):5679-85
pubmed: 20631066
Cancer Res. 2015 Mar 15;75(6):950-62
pubmed: 25736687
Semin Cancer Biol. 2015 Dec;35 Suppl:S199-S223
pubmed: 25865775
Cancer Res. 2017 Jul 1;77(13):3431-3441
pubmed: 28536280
Int Immunopharmacol. 2020 Oct;87:106807
pubmed: 32683299
Lancet Oncol. 2019 Aug;20(8):e434-e442
pubmed: 31364595
J Cell Sci. 2012 Dec 1;125(Pt 23):5591-6
pubmed: 23420197
Nat Rev Cancer. 2019 Mar;19(3):133-150
pubmed: 30755690
Oncotarget. 2018 Nov 16;9(90):36083-36101
pubmed: 30546829
Nat Rev Cancer. 2017 May;17(5):302-317
pubmed: 28303905
J Clin Oncol. 2019 Jun 20;37(18):1558-1565
pubmed: 31067138
J Clin Oncol. 2020 Sep 1;38(25):2830-2838
pubmed: 32484754
Clin Cancer Res. 2020 Sep 15;26(18):4723-4736
pubmed: 32409306
J Immunother Cancer. 2019 Jul 23;7(1):194
pubmed: 31337426
Nat Commun. 2019 Aug 20;10(1):3745
pubmed: 31431623
Nat Rev Clin Oncol. 2019 Feb;16(2):123-135
pubmed: 30401936
Nat Metab. 2019 Jan;1(1):158-171
pubmed: 31106291
Proc Natl Acad Sci U S A. 2013 Jan 29;110(5):E415-24
pubmed: 23271806